인쇄하기
취소
|
It’s getting more interesting and interesting. Competition is getting fiercer over the 2nd position for anticoagulants after warfarin.
According to the IMS’s data, the total prescriptions of new oral anticoagulants(NOAC) was approximately KRW 15.3 billion in the 1st quarter of 2016. The market size was increased by more than 370% compared to the same quarter of the last year. It is hard to rea...